Skip to content

Clinical trials

Completed Pulmonary Arterial Hypertension trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Status: Completed Country / region: Canada Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20063
20071
20083
20094
20103
20115
20124
20131
20141
20152
20162
20172
20182
20193
20214
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion10
United Therapeutics6
Bayer5
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
Gilead Sciences2
GlaxoSmithKline2
Laval University2
Merck Sharp & Dohme LLC2
Ottawa Heart Institute Research Corporation2
Altavant Sciences GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension46
Hypertension, Pulmonary21
Hypertension3
Adenoviridae Infections1
Anxiety Disorders1
Arrhythmias, Cardiac1
Autistic Disorder1
Bipolar Disorder1
Bradycardia1
Cardiovascular Diseases1

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.